While many are familiar with the business operations of Alibaba Group Holdings (if not, you can check out a review post I have done about this HK- and US-listed company on Instagram here), but the same cannot be said for the Hong Kong-listed Alibaba Health Information Technology Limited (SEHK:0241), or Alibaba Health for short. This post was originally posted here. The writer, Jun Yuan Lim is a veteran community member and blogger on InvestingNote, with a username known as @ljunyuan and has close to 2100 followers. Prior to Alibaba Group Holdings’ acquisition of a major ownership in the company in 2015, it was known as CITIC 21 CN Company Limited. As the name “Alibaba Health” implies, it is in the healthcare business where it offers a range of pharmaceutical and over-the-counter (or OTC for short) drugs, nutritional supplements, medical devices, contact lenses, along with other health-related products through its online shopping site...